Resistance of human immunodeficiency virus type 1 to protease inhibitors: Selection of resistance mutations in the presence and absence of the drug

Journal of General Virology

Volumn 77, Issue 3, 1996, Pages 419-426

  Borman, Andrew M ^a,b   Paulous, Sylvie ^a   Clavel, François ^a  

^a INSTITUT PASTEUR   (France)

^b CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; PROTEINASE INHIBITOR;

ARTICLE; CONTROLLED STUDY; DRUG RESISTANCE; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0030065565     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-77-3-419     Document Type: Article

References (35)

1. CHARNEAU, P., ALIZON, M. & CLAVEL, F. (1992). A second origin of plus strand synthesis is required for optimal HIV replication. Journal of Virology 66, 2814-2820.
2. COFFIN, J. (1995) HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy. Science 267, 483-489.
3. CONDRA, J., SCHLEIF, W., BLAHY, O., GABRYELSKI, L., GRAHAM, D., QUINTERO, J., RHODES. A., BOBBINS. H., ROTH, E., SHIVAPRAKASH, M., TITUS, D., YANG, T., TEPPLER, H., SQUIRES, K., DEUTSCH, P. & EMINI, E (1995). In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors. Nature 374, 569-571.
4. CONLON, C., KLENERMAN, P., EDWARDS, A., LARDER, B. & PHILLIPS, R. (1994). Heterosexual transmission of human immunodeficiency virus type 1 variants associated with zidovudine resistance. Journal of Infectious Diseases 169, 411-415
5. DANZIANI, F., ANTONELLI. G., TURRIZIANI, O., RIVA, E., DONG, G. & BELLAROSA, D. (1993). In vitro selection of human immunodeficiency virus type 1 resistant to Ro 31-8959 proteinase inhibitor. Antiviral Chemistry and Chemotherapy 4, 335-339.
6. DEBOUCK, C. (1992). The HIV-1 protease as a therapeutic target for AIDS AIDS Research and Human Retroviruses 8, 153-164.
7. DOYON, L., POULIN, F , PILOTE, L., CLOUETTE, C., THIBEAULT, D., CROTEAU, G. & LAMARRE, D. (1995). Protease inhibitor resistant HIV-1 variants containing an altered protease cleavage site. Abstracts of the 2nd National Conference on Human Retroviruses, Washington, DC, USA, January 1995.
8. EL-FARRASH, M., KURODA, M., KITAZAKI, T., MASUDA, T., KATO, K., HATANAKA, M. & HARADA, S. (1994) Generation and characterization of a human immunodeficiency virus type 1 (HIV-1)mutant resistant to an HIV-1 protease inhibitor. Journal of Virology 68, 233-239.
9. HARADA, S., KOYANAGI, Y. & YAMAMOTO, N. (1985). Infection of HTLV-III/LAV in HTLV-I-carrying cells MT-2 and MT-4 and application in a plaque assay. Science 229, 563-566.
10. HO, D., TOYOSHIMA., T., MO, H., KEMPF, D., NORBECK, D , CHEN, C., WIDEBURG, N., BURT, S., ERICKSON, J. & SINGH, M. (1994). Characterization of human immunodeficiency virus type 1 variants with increased resistance to a C2-symmetric protease inhibitor. Journal of Virology 68, 2016-2020.
11. HO, D., NEUMANN, A., PERELSON, A., CHEN, W., LEONARD, J. & MARKOWITZ, M. (1995) Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373, 123-126.
12. HUNTER, E. (1994). Macromolecular interactions in the assembly of HIV and other retroviruses. Seminars in Virology 5, 71-83.
13. KAGEYAMA, S., WEINSTEIN, J., SHIRASAKA, T., KEMPF, D., NORBECK, D., PLATTNER, J., ERICKSON, J. & MITSUYA, H. (1992). In vitro inhibition of human immunodeficiency virus (HIV) type 1 replication by C2 symmetry-based HIV protease inhibitors as single agents or in combination. Antimicrobial Agents and Chemotherapy 36, 926-933.
14. KAPLAN, A., MICHAEL, S , WEHBIE, R., KNIGGE, M., PAUL, D., EVERITT, L., KEMPF, D., NORBECK, D., ERICKSON, J. & SWANSTROM, R. (1994). Selection of multiple human immunodeficiency virus type 1 variants that encode viral proteases with decreased sensitivity to an inhibitor of the viral protease. Proceedings of the National Academy of Sciences, USA 91, 5597-5601
15. KEMPF, D., MARSH, K., PAUL, D., KNIGGE, M , NORBECK, D., KOHLBRENNE, R. W., CODACOVI, L., VASAVANONDA, S., BRYANT, P. & WANG, X. (1991). Antiviral and pharmacokinetic properties of C2 symmetric inhibitors of the human immunodeficiency virus type 1 protease. Antimicrobial Agents and Chemotherapy 35, 2209-2214.
16. KEMPF, D., CODACOVI, L., WANG, X., KOHLBRENNER, W., WEDEBURG, N., SALDIVAR, A., VASAVANONDA, S., MARSH, K., BRYANT, P., SHAM, H , GREEN, B., BETEBENNER, B , ERICKSON, J. & NORBECK, D. (1993). Symmetry-based inhibitors of HIV protease. Structure-activity studies of acylated 2,4-diamino-1,5-diphenyl-3-hydroxypentane and 2,5-diamino-1,6-diphenyl-3,4-diol. Journal of Medicinal Chemistry 36, 320-330.
17. KOHL, N., EMINI, E., SCHLEIF, W., DAVIS, L., HEIMBACH, J., DIXON, R., SCOLNICK, E. & SIGAL, I. (1988). Active human immunodeficiency virus protease is required for viral infectivity. Proceedings of the National Academy of Sciences. USA 85, 4686-4690.
18. KORT, J., BILELLO, J., BAUER, G. & DRUSANO, G. (1993). Preclinical evaluation of antiviral activity and toxicity of Abbott A77003, an inhibitor of the human immunodeficiency virus type 1 protease. Antimicrobial Agents and Chemotherapy 37, 115-119.
19. KRAUSSLICH, H. G. & WIMMER, E. (1988). Viral proteinases. Annual Review of Biochemistry 54, 701-754.
20. LAM, P., JADHAV, P., EYERMANN, C., HODGE, C., RU, Y., BACHELER, L., MEEK, J., OTTO, M., RAYNER, M., WONG, Y., CHANG, C., WEBER, P., JACKSON, D., SHARPE, T. & ERICKSON-VIITANEN, S. (1994). Rational design of potent, bioavailable, nonpeptide cyclic ureas as HIV protease inhibitors. Science 263, 380-384.
21. LAMARRE, D. (1995). Molecular basis of HIV-1 resistance to protease inhibitors Structural flexibility of the protease and second-site compensatory mutations in cleavage sites. Abstracts of the 4th International Workshop on HIV Drug Resistance, Sardinia, Italy, 1995.
22. LOEB, D. D., SWANSTROM, R., EVERITT, L., MANCHESTER, M., STAMPER, S. E. & HUTCHISON, C A. (1989). Complete mutagenesis of the HIV-1 protease. Nature 340, 397-400.
23. MARKOWITZ, M., MO, H., KEMPF, D., NORBECK, D., BHAT, T., ERICKSON, J. & HO, D. (1995). Selection and analysis of human immunodeficiency virus type 1 variants with increased resistance to ABT-538, a novel protease inhibitor. Journal of Virology 69, 701-706.
24. MASQUELIER, B., PELLEGRIN, I., NEAU, D., LEGRAND, E., PATY, M., PELLEGRIN, J., RAGNAUD, J. & FLEURY, H. (1995). A genotypic study of zidovudine and didanosine resistance in proviral DNA from patients with HIV-1 primary infection. Abstracts of the 2nd Notional Conference on Human Retroviruses, Washington, DC, USA, January 1995.
25. MILLER. M., SCHNEIDE, R. J., SATHYANARAYANA, B., TOTH, M., MARSHALL, G., CLAWSON, L., SELK, L., KENT, S. & WLODAWER, A. (1989). Structure of complex of synthetic HIV-1 protease with a substrate-based inhibitor at 2-3 Å resolution. Science 246, 1149-1152.
26. MYERS, G., WAIN-HOBSON, S., HENDERSON, L., KORBER, B., JEANG, K. & PAVLAKIS, G. (editors) (1994). Human Retroviruses and AIDS. Los Alamos: Los Alamos National Laboratory.
27. NAJERA, I., HOLGUIN, A , QUINONES-MATEU, M., MUNOZ-FERNANDEZ, M., NAJERA, R., LOPEZ-GALINDEZ, C. & DOMINGO, E. (1995). Pol gene quasispecies of human immunodeficiency virus: mutations associated with drug resistance in virus from patients undergoing no drug therapy. Journal of Virology 69, 23-31.
28. NAVIA, M., FITZGERALD, P., MCKEEVER, B., LEU, C., HEIMBACH, J., HERBER, W., SIGAL, I., DARKE, P. & SPRINGER, J. (1989). Three-dimensional structure of aspartyl protease from human immunodeficiency virus HIV-1. Nature 337, 615-620.
29. OTTO, M , GARBER, S., WINSLOW, D., REID, C., ALDRICH, P , JADHAV, P., PATTERSON, C., HODGE, C. & CHENG, Y. (1993). In vitro isolation and identification of human immunodeficiency virus (HIV) variants with reduced sensitivity to C-2 symmetrical inhibitors of HIV type 1 protease. Proceedings of the National Academy of Sciences, USA 90, 7543-7547.
30. PATICK, A., ROSE, R., GREYTOCK, J., BECHTOLD, C., HERMSMEIER, M., CHEN, P., BARRISH, J., ZAHLER, R., COLONNO, R & LIN, P. (1995). Characterization of a human immunodeficiency virus type 1 variant with reduced sensitivity to an aminodiol protease inhibitor. Journal of Virology 69, 2148-2152.
31. PEARL, L. & TAYLOR, W. (1987). A structural model for the retroviral proteases. Nature 329, 352-354.
32. ROBERTS, N., MARTIN, J., KINCHINGTON, D., BROADHURST, A., CRAIG, J., DUNCAN, I., GALPIN, S., HANDA, B., KAY, J., KROHN, A., LAMBERT, R., MERRETT, J., MILLS, J., PARKES, K., REDSHAW, S., RITCHIE, A., TAYLOR, D., THOMAS, G. & MACHIN, P (1990). Rational design of peptide-based HIV proteinase inhibitors. Science 248, 358-361.
33. SARDANA, V., SCHLABACH, A., GRAHAM, P., BUSH, B., CONDRA, J., CULBERSON, J., GOTLIB, L., GRAHAM, D., KOHL, N. & LAFEMINA, R. (1994) Human immunodeficiency virus type 1 protease inhibitors: evaluation of resistance engendered by amino acid substitutions in the enzyme's substrate binding site. Biochemistry 33, 2004-2010.
34. VACCA, J., DORSEY, B., SCHLEIF, W., LEVIN, R., MCDANIEL, S., DARKE, P., ZUGAY, J., QUINTERO, J , BLAHY, O., ROTH, E., SARDANA, V., SCHLABACK, A., GRAHAM, P., CONDRA, J., GOTLIB, L., HOLLOWAY, L , LIN, J., CHEN, I., VASTAG, K., OSTOVIC, D., ANDERSON, P., EMINI, E. & HUFF, J. (1994). L-735,524: an orally bioavailable human immunodeficiency virus type 1 protease inhibitor. Proceedings of the National Academy of Sciences, USA 91, 4096-4100.
35. WAIN-HOBSON, S., SONIGO, P., DANOS, O., COLE, S & ALIZON, M. (1985). Nucleotide sequence of the AIDS virus, LAV. Cell 40, 9-17